Gene · 440
Papers1,669
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 1,669
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Lipoylation is dependent on the ferredoxin FDX1 and dispensable under hypoxia in human cells. | J Biol Chem | 2023 | 37481209 | PubTator, text mining | PubMed |
| Methylseleninic acid overcomes gefitinib resistance through asparagine-MET-TOPK signaling axis in non-small cell lung cancer cells. | Biochem Pharmacol | 2023 | 37481142 | PubTator, text mining | PubMed |
| STAG2 inactivation reprograms glutamine metabolism of BRAF-mutant thyroid cancer cells. | Cell Death Dis | 2023 | 37479689 | PubTator, text mining | PubMed |
| Editorial: Ferroptosis in stroke, neurotrauma and neurodegeneration, volume II. | Front Cell Neurosci | 2023 | 37475985 | PubTator, text mining | PubMed |
| Back to the future: the amazing journey of the therapeutic anti-leukemia enzyme asparaginase Erwinia chrysanthemi. | Haematologica | 2023 | 37470157 | PubTator, text mining | PubMed |
| Life span-associated ferroptosis-related genes identification and validation for hepatocellular carcinoma patients as hepatitis B virus carriers. | J Clin Lab Anal | 2023 | 37461802 | PubTator, text mining | PubMed |
| Transcriptional regulation of amino acid metabolism by KDM2B, in the context of ncPRC1.1 and in concert with MYC and ATF4. | bioRxiv | 2023 | 37461630 | PubTator, text mining | PubMed |
| Dietary Manipulation of Amino Acids for Cancer Therapy. | Nutrients | 2023 | 37447206 | PubTator, text mining | PubMed |
| CEBP-β and PLK1 as Potential Mediators of the Breast Cancer/Obesity Crosstalk: In Vitro and In Silico Analyses. | Nutrients | 2023 | 37447165 | PubTator, text mining | PubMed |
| Effects of Capsaicin on Glucose Uptake and Consumption in Hepatocytes. | Molecules | 2023 | 37446918 | PubTator, text mining | PubMed |
| Cathepsin B Is Not an Intrinsic Factor Related to Asparaginase Resistance of the Acute Lymphoblastic Leukemia REH Cell Line. | Int J Mol Sci | 2023 | 37446393 | PubTator, text mining | PubMed |
| Expression and Activity of the Transcription Factor CCAAT/Enhancer-Binding Protein β (C/EBPβ) Is Regulated by Specific Pulse-Modulated Radio Frequencies in Oligodendroglial Cells. | Int J Mol Sci | 2023 | 37446309 | PubTator, text mining | PubMed |
| Targeting Metabolic Vulnerabilities in Epstein-Barr Virus-Driven Proliferative Diseases. | Cancers (Basel) | 2023 | 37444521 | PubTator, text mining | PubMed |
| Elevated glutamate impedes anti-HIV-1 CD8 + T cell responses in HIV-1-infected individuals on antiretroviral therapy. | Commun Biol | 2023 | 37419968 | PubTator, text mining | PubMed |
| Upregulation of hsa_circ_0002003 promotes hepatocellular carcinoma progression. | BMC Cancer | 2023 | 37400785 | PubTator, text mining | PubMed |
| Glutamine and amino acid metabolism as a prognostic signature and therapeutic target in endometrial cancer. | Cancer Med | 2023 | 37387559 | PubTator, text mining | PubMed |
| Arginine regulates HSPA5/BiP translation through ribosome pausing in triple-negative breast cancer cells. | Br J Cancer | 2023 | 37386138 | PubTator, text mining | PubMed |
| DOT1L activity affects neural stem cell division mode and reduces differentiation and ASNS expression. | EMBO Rep | 2023 | 37382163 | PubTator, text mining | PubMed |
| Glutamine metabolism genes prognostic signature for stomach adenocarcinoma and immune infiltration: potential biomarkers for predicting overall survival. | Front Oncol | 2023 | 37377916 | PubTator, text mining | PubMed |
| Potential Alternative Therapeutic Modalities for Management Head and Neck Squamous Cell Carcinoma: A Review. | Cancer Control | 2023 | 37328298 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/440/papers?page=11